C-Peptide EIA Kit
安全性情報
- リスクと安全性に関する声明
- 危険有害性情報のコード(GHS)
絵表示(GHS) |
|
注意喚起語 |
警告 |
危険有害性情報 |
コード |
危険有害性情報 |
危険有害性クラス |
区分 |
注意喚起語 |
シンボル |
P コード |
H290 |
金属腐食のおそれ |
金属腐食性物質 |
1 |
警告 |
|
P234, P390, P404 |
|
注意書き |
P234 |
他の容器に移し替えないこと。 |
P390 |
物的被害を防止するためにも流出したものを吸収 すること。 |
|
C-Peptide EIA Kit 価格
もっと(2)
メーカー |
製品番号 |
製品説明 |
CAS番号 |
包装 |
価格 |
更新時間 |
購入 |
Sigma-Aldrich Japan
|
RAB0326 |
for serum, plasma, culture supernatant and cell lysates
C-Peptide EIA Kit for serum, plasma, culture supernatant and cell lysates |
|
1KIT |
¥106000 |
2024-03-01 |
購入 |
Sigma-Aldrich Japan
|
RAB0326 |
for serum, plasma, culture supernatant and cell lysates
C-Peptide EIA Kit for serum, plasma, culture supernatant and cell lysates |
|
1kt |
¥79800 |
2018-12-25 |
購入 |
C-Peptide EIA Kit 化学特性,用途語,生産方法
使用
For research use only. Not for use in diagnostic procedures.
Please refer to the attached General ELISA KIT
Procedure (sandwich, competitive & Indirect ELISA)
一般的な説明
The C-Peptide Enzyme Immunoassay (EIA) Kit is an in vitro quantitative assay for detecting C-Peptide peptide based on the principle of Competitive Enzyme Immunoassay. EIA-CPE-1 only detects C-peptide, not Insulin A or B chain.
Biochem/physiol Actions
C-peptide inhibits endothelial dysfunction under high glucose conditions via inhibition of nuclear factor-κB (NF-κB) pathway. Experimental studies suggest that prolonged dosage of physiological concentration of C-peptide to type 1 diabetes patients minimizes diabetes-induced complications, such as glomerular hypertrophy and mesangial matrix expansion by interrupting transforming growth factor β1 (TGF-β1) and tumor necrosis factor α (TNFα) signaling pathway. C-peptide reduces diabetes-induced glomerular hyperfiltration by contraction of the afferent arteriole, dilation of the efferent arteriole, and by inhibition of tubular reabsorption. C-Peptide also plays a crucial role in renal pathophysiology. C-peptide binds to a cell surface receptor that is likely to be G-protein coupled. This interaction stimulates various cellular functions such as increasing intracellular Ca2+ concentration, enhancing PI3-K (phosphoinositide 3-kinase) activity, increased endothelial nitric oxide synthase (eNOS) transcription, and activation of the Na+/K+ ATPase and mitogen-activated protein kinase (MAPK) signaling pathway.
C-Peptide EIA Kit 上流と下流の製品情報
原材料
準備製品
C-Peptide EIA Kit 生産企業
Global( 2)Suppliers